KDT-3594

· Kissei Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KDT-3594, covering 2021-02-17 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease [Phase 2]